| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.06 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.06 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |